126 related articles for article (PubMed ID: 27004346)
1. EVALUATION OF MODEL FOR END-STAGE LIVER DISEASE SCORE CUT OFF VALUES IN PATIENTS WITH HEPATIC ENCEPHALOPATHY.
Khurram M; Qayyum W; Umar M; ul Abedin Z; Bushra HT
J Ayub Med Coll Abbottabad; 2015; 27(4):886-9. PubMed ID: 27004346
[TBL] [Abstract][Full Text] [Related]
2. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
3. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
[TBL] [Abstract][Full Text] [Related]
4. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites.
Yoo HY; Edwin D; Thuluvath PJ
Am J Gastroenterol; 2003 Jun; 98(6):1395-9. PubMed ID: 12818287
[TBL] [Abstract][Full Text] [Related]
5. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of the predictive value of the model for end-stage liver disease scoring system combined with the indocyanine green clearance test for short-term prognosis of acute-on-chronic hepatitis B liver failure].
Tang K; Shan J; Tian F; Cao W
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):190-4. PubMed ID: 24824120
[TBL] [Abstract][Full Text] [Related]
7. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
Hu XP; Gao J
World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
[TBL] [Abstract][Full Text] [Related]
8. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong RJ; Gish RG; Ahmed A
Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
[TBL] [Abstract][Full Text] [Related]
9. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury.
Schmidt LE; Larsen FS
Hepatology; 2007 Mar; 45(3):789-96. PubMed ID: 17326205
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Model of End-Stage Liver Disease Score in Predicting Outcomes of Carotid Endarterectomy.
Krafcik BM; Farber A; Eslami MH; Kalish JA; Rybin D; Doros G; King EG; Siracuse JJ
Vasc Endovascular Surg; 2016 Aug; 50(6):380-4. PubMed ID: 27334479
[TBL] [Abstract][Full Text] [Related]
11. The sequential organ failure assessment (SOFA) score is prognostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol (acetaminophen) overdose.
Craig DG; Reid TW; Wright EC; Martin KG; Davidson JS; Hayes PC; Simpson KJ
Aliment Pharmacol Ther; 2012 Mar; 35(6):705-13. PubMed ID: 22260637
[TBL] [Abstract][Full Text] [Related]
12. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
[TBL] [Abstract][Full Text] [Related]
13. Association of Model for End-Stage Liver Disease Score With Mortality in Emergency General Surgery Patients.
Havens JM; Columbus AB; Olufajo OA; Askari R; Salim A; Christopher KB
JAMA Surg; 2016 Jul; 151(7):e160789. PubMed ID: 27192189
[TBL] [Abstract][Full Text] [Related]
14. Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases.
El-Ghannam MT; Hassanien MH; El-Talkawy MD; Saleem AAA; Sabry AI; Abu Taleb HM
J Clin Diagn Res; 2017 Jun; 11(6):OC12-OC16. PubMed ID: 28764217
[TBL] [Abstract][Full Text] [Related]
15. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosis.
Lahdou I; Sadeghi M; Oweira H; Fusch G; Daniel V; Mehrabi A; Jung G; Elhadedy H; Schmidt J; Sandra-Petrescu F; Iancu M; Opelz G; Terness P; Schefold JC
Hum Immunol; 2013 Jan; 74(1):60-6. PubMed ID: 23046794
[TBL] [Abstract][Full Text] [Related]
17. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
[TBL] [Abstract][Full Text] [Related]
18. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis].
Zhou Q; Tan D; Yi Z; Zheng Y; Lu M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):388-94. PubMed ID: 23645239
[TBL] [Abstract][Full Text] [Related]
20. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.
Lattanzi B; Nardelli S; Pigliacelli A; Di Cola S; Farcomeni A; D'Ambrosio D; Gioia S; Ginanni Corradini S; Lucidi C; Mennini G; Rossi M; Merli M; Riggio O
Dig Liver Dis; 2019 Nov; 51(11):1508-1512. PubMed ID: 31601536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
